SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Cytokinetics Inc. (CYTK) on Wednesday reported a loss of $160.5 million in its third quarter.
The South San Francisco, California-based company said it had a loss of $1.36 per share.
The results did not meet Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.27 per share.
The biopharmaceutical company posted revenue of $463,000 in the period, which also did not meet Street forecasts. Five analysts surveyed by Zacks expected $1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTK at https://www.zacks.com/ap/CYTK
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
